Ellagitannins in cancer chemoprevention
Cancer still represents the second leading cause of death, after heart diseases. It is estimated that in the next 15 years the number of new cancer cases will increase by 70%. Therefore, new innovative preventive and therapeutic strategies to contrast cancer-associated mortality are needed.
Read more